Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | WYE-125132 |
Synonyms | |
Therapy Description |
WYE-125132 (WYE-132) inhibits mTOR signaling through mTORC1/2, thereby preventing cell proliferation (PMID: 20068177, PMID: 26293898). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
WYE-125132 | WYE-132 | mTOR Inhibitor 51 | WYE-125132 (WYE-132) inhibits mTOR signaling through mTORC1/2, thereby preventing cell proliferation (PMID: 20068177, PMID: 26293898). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PIK3CA E545K | breast cancer | sensitive | WYE-125132 | Preclinical | Actionable | In a preclinical study, WYE-125132 inhibited proliferation of breast cancer cells with a PIK3CA E545K mutation (PMID: 20068177). | 20068177 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|